AAVXF
Price
$7.28
Change
+$1.47 (+25.30%)
Updated
Jun 11 closing price
Capitalization
635.47M
AGTX
Price
$0.03
Change
+$0.01 (+50.00%)
Updated
Jul 15 closing price
Capitalization
1.18M
Interact to see
Advertisement

AAVXF vs AGTX

Header iconAAVXF vs AGTX Comparison
Open Charts AAVXF vs AGTXBanner chart's image
Abivax SA
Price$7.28
Change+$1.47 (+25.30%)
Volume$300
Capitalization635.47M
Agentix
Price$0.03
Change+$0.01 (+50.00%)
Volume$1.3K
Capitalization1.18M
AAVXF vs AGTX Comparison Chart in %
Loading...
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AAVXF vs. AGTX commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Hold and AGTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (AAVXF: $7.28 vs. AGTX: $0.03)
Brand notoriety: AAVXF and AGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 139% vs. AGTX: 3%
Market capitalization -- AAVXF: $635.47M vs. AGTX: $1.18M
AAVXF [@Biotechnology] is valued at $635.47M. AGTX’s [@Biotechnology] market capitalization is $1.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 0 FA rating(s) are green whileAGTX’s FA Score has 1 green FA rating(s).

  • AAVXF’s FA Score: 0 green, 5 red.
  • AGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, AGTX is a better buy in the long-term than AAVXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAVXF’s TA Score shows that 4 TA indicator(s) are bullish while AGTX’s TA Score has 4 bullish TA indicator(s).

  • AAVXF’s TA Score: 4 bullish, 2 bearish.
  • AGTX’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, AGTX is a better buy in the short-term than AAVXF.

Price Growth

AAVXF (@Biotechnology) experienced а 0.00% price change this week, while AGTX (@Biotechnology) price change was +25.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.21%. For the same industry, the average monthly price growth was +15.57%, and the average quarterly price growth was +33.92%.

Industries' Descriptions

@Biotechnology (+2.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($635M) has a higher market cap than AGTX($1.18M). AAVXF YTD gains are higher at: -34.118 vs. AGTX (-83.406). AGTX has higher annual earnings (EBITDA): -352.07K vs. AAVXF (-170.04M). AAVXF has more cash in the bank: 104M vs. AGTX (8.27K). AGTX has less debt than AAVXF: AGTX (198K) vs AAVXF (92.6M). AAVXF (0) and AGTX (0) have equivalent revenues.
AAVXFAGTXAAVXF / AGTX
Capitalization635M1.18M53,814%
EBITDA-170.04M-352.07K48,297%
Gain YTD-34.118-83.40641%
P/E RatioN/AN/A-
Revenue00-
Total Cash104M8.27K1,257,101%
Total Debt92.6M198K46,768%
FUNDAMENTALS RATINGS
AAVXF vs AGTX: Fundamental Ratings
AAVXF
AGTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
6265
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGTX's Valuation (3) in the null industry is somewhat better than the same rating for AAVXF (66). This means that AGTX’s stock grew somewhat faster than AAVXF’s over the last 12 months.

AGTX's Profit vs Risk Rating (100) in the null industry is in the same range as AAVXF (100). This means that AGTX’s stock grew similarly to AAVXF’s over the last 12 months.

AAVXF's SMR Rating (99) in the null industry is in the same range as AGTX (100). This means that AAVXF’s stock grew similarly to AGTX’s over the last 12 months.

AAVXF's Price Growth Rating (62) in the null industry is in the same range as AGTX (65). This means that AAVXF’s stock grew similarly to AGTX’s over the last 12 months.

AAVXF's P/E Growth Rating (100) in the null industry is in the same range as AGTX (100). This means that AAVXF’s stock grew similarly to AGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AAVXFAGTX
RSI
ODDS (%)
Bearish Trend 7 days ago
43%
Bullish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
41%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
63%
MACD
ODDS (%)
Bearish Trend 4 days ago
35%
Bullish Trend 4 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
30%
Bullish Trend 4 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
25%
Bullish Trend 4 days ago
62%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 7 days ago
54%
Aroon
ODDS (%)
Bullish Trend 4 days ago
32%
Bearish Trend 4 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
METCB13.950.84
+6.41%
Ramaco Resources
CCEP96.840.71
+0.74%
Coca-Cola Europacific Partners plc
CVI28.60-0.33
-1.14%
CVR Energy
AIOT4.42-0.11
-2.43%
PowerFleet Inc.
VYNE1.16-0.04
-3.33%
VYNE Therapeutics

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
N/A
BPMUF - AAVXF
47%
Loosely correlated
N/A
CSCI - AAVXF
46%
Loosely correlated
+5.61%
SRPT - AAVXF
45%
Loosely correlated
-35.94%
ABCZF - AAVXF
31%
Poorly correlated
N/A
IMNN - AAVXF
28%
Poorly correlated
-8.50%
More

AGTX and

Correlation & Price change

A.I.dvisor tells us that AGTX and SMMT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGTX and SMMT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGTX
1D Price
Change %
AGTX100%
N/A
SMMT - AGTX
31%
Poorly correlated
-5.18%
RLAY - AGTX
30%
Poorly correlated
-4.11%
VRDN - AGTX
25%
Poorly correlated
-3.11%
AAVXF - AGTX
15%
Poorly correlated
N/A
ABCZF - AGTX
11%
Poorly correlated
N/A
More